Position in PGEN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$19,776,876
+$10,433,453 QoQ
Shares Held
3,469,628
+43.7% QoQ
Ownership
0.969%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 210 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 85%
Shared 0%
None 15%
Common Shares in PGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. PGEN ranks #100 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in PGEN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,776,876 | 3,469,628 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $9,343,423 | 2,414,322 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $13,348,923 | 3,193,523 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $6,519,605 | 1,981,644 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $2,898,181 | 2,040,974 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $1,539,330 | 1,033,110 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,253,962 | 1,119,611 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $1,154,579 | 1,215,350 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $1,591,537 | 1,007,304 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $1,541,823 | 1,063,328 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $1,694,172 | 1,264,309 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $1,380,875 | 972,449 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $1,081,412 | 940,360 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $966,981 | 912,249 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,263,697 | 831,381 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,855,107 | 875,052 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,208,888 | 902,158 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $2,411,059 | 1,142,683 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $3,585,212 | 966,365 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $4,615,586 | 924,968 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $7,973,013 | 1,222,855 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $6,096,271 | 884,800 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $7,391,725 | 724,679 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $3,803,078 | 1,086,594 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $3,406,343 | 682,634 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $2,245,916 | 660,564 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||